Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
TransUnion
TRU
$15.4B
| $5.65M | 0.01% |
182,800
-371,300
| -67% | -$11.7M |
|
|
FBNK
1577
DELISTED
First Connecticut Bancorp, Inc
FBNK
| $5.63M | 0.01% |
248,700
+43,200
| +21% | +$871K |
|
|
UAM
1578
DELISTED
Universal American Corp
UAM
| $5.63M | 0.01% |
566,126
+422,100
| +293% | +$3.71M |
|
|
RNWK
1579
DELISTED
RealNetworks Inc
RNWK
| $5.63M | 0.01% |
1,158,378
-23,100
| -2% | -$109K |
|
|
SHYF
1580
DELISTED
The Shyft Group
SHYF
| $5.63M | 0.01% |
608,248
+103,000
| +20% | +$924K |
|
1581
Pembina Pipeline
PBA
$28.7B
| $5.61M | 0.01% |
179,106
-205,758
| -53% | -$6.22M |
|
1582
CRH
CRH
$64.6B
| $5.6M | 0.01% |
+163,000
| New | +$5.43M |
|
|
WFM
1583
DELISTED
Whole Foods Market Inc
WFM
| $5.59M | 0.01% |
181,648
+103,848
| +133% | +$3.12M |
|
1584
Aware
AWRE
$26.4M
| $5.58M | 0.01% |
915,272
+71,933
| +9% | +$397K |
|
|
FSB
1585
DELISTED
Franklin Financial Network, Inc.
FSB
| $5.57M | 0.01% |
133,100
+127,500
| +2,277% | +$4.64M |
|
1586
Magna International
MGA
$18.8B
| $5.56M | 0.01% |
128,200
+93,216
| +266% | +$3.92M |
|
1587
H.B. Fuller
FUL
$3.38B
| $5.56M | 0.01% |
115,000
-1,400
| -1% | -$64.9K |
|
1588
Petrobras
PBR
$115B
| $5.56M | 0.01% |
549,600
+138,100
| +34% | +$1.47M |
|
|
SPA
1589
DELISTED
Sparton
SPA
| $5.55M | 0.01% |
232,743
+16,808
| +8% | +$407K |
|
|
ALJ
1590
DELISTED
Alon USA Energy Inc
ALJ
| $5.54M | 0.01% |
486,800
+258,400
| +113% | +$2.42M |
|
1591
Upbound Group
UPBD
$1.14B
| $5.54M | 0.01% |
492,210
+54,700
| +13% | +$609K |
|
|
ANW
1592
DELISTED
Aegean Marine Petroleum Network
ANW
| $5.53M | 0.01% |
544,300
+136,700
| +34% | +$1.36M |
|
1593
NACCO Industries
NC
$322M
| $5.52M | 0.01% |
266,997
+27,137
| +11% | +$517K |
|
1594
HCI Group
HCI
$2.29B
| $5.51M | 0.01% |
139,500
-2,300
| -2% | -$73.4K |
|
1595
Baytex Energy
BTE
$3.06B
| $5.5M | 0.01% |
+1,127,191
| New | +$4.89M |
|
|
BSQR
1596
DELISTED
BSQUARE Corporation
BSQR
| $5.49M | 0.01% |
937,875
-11,000
| -1% | -$56.1K |
|
1597
Grupo Cibest SA
CIB
$22.8B
| $5.47M | 0.01% |
149,100
-134,600
| -47% | -$4.92M |
|
|
AIRM
1598
DELISTED
Air Methods Corp
AIRM
| $5.46M | 0.01% |
+171,600
| New | +$5.29M |
|
1599
Manchester United
MANU
$4.17B
| $5.45M | 0.01% |
382,700
+123,780
| +48% | +$1.89M |
|
|
WSR
1600
DELISTED
Whitestone REIT
WSR
| $5.43M | 0.01% |
377,800
-89,100
| -19% | -$1.2M |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.